Please Wait.....
Report
Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets
Market Research Report I 2023-10-13 I 131 Pages I BCC Research
Description
Report Scope:
The scope of the report includes biologics CDMO services, industries, initiatives, patents, and companies. The markets for biologics CDMO are given for 2020, 2021, 2022, 2023 and 2028.
This report explains why biologics CDMO is important in pharmaceutical and biotechnology industry. It then discusses some of the significant research initiatives that are impacting biologics CDMO. The main market-driving forces are also discussed.
The report examines the markets by product type, cell line type and region. The report provides market data and forecasts for biologics CDMO by product type, including biologics and biosimilars. The specific regional markets covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW).
In the report BCC Research summarizes the main industry acquisitions and strategic alliances from January 2020 through December 2022.
Report Includes:
- 40 data tables and 10 additional tables
- An up-to-date overview and industry analysis of the global markets for biologics contract development and manufacturing organizations (CDMO)
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for biologics CDMO market in USD million values, and their corresponding market share analysis based on the product type, cell line type, and geographic region
- In-depth information (facts and figures) concerning the market growth drivers, opportunities and challenges, prospects, technologies, regulatory scenarios, and the impact of macroeconomic variables on biologics CDMO marketplace
- Discussion of ESG developments in global CDMO services market, with emphasis on importance of ESG, consumer attitudes, risks and opportunity assessment, and ESG followed practices
- Identification of the pharma companies that are considered as leaders in their field, as well as technological means these companies are using to exploit their markets and dominate the market in their fields
- Market outlook and opportunity assessment of the industry structure for biologics CDMO services, and evaluation of ongoing clinical trials and R&D activities estimating current and future market demand
- Insight into the growth development strategies of the key market players operating within the global market; their key competitive landscape and company share analysis
- Analysis of the company competitive landscape based on recent developments, key financials, and operational integration
- Company profiles of major players within the industry, including Lonza Group, WuXi Biologics, Samsung Biologics, Boehringer Ingelheim, and Catalent Inc.
Executive Summary
Summary:
Contract development and manufacturing organizations serve the pharmaceutical industry and provide clients with services such as drug development, process development, analytical testing, formulation development, scale-up, manufacturing, packaging and distribution. These services can be provided on a standalone basis or as part of an end-to-end service offering.
A biologics contract development and manufacturing organization (CDMO) provides pharmaceutical companies with biological medical product development and manufacturing services. This type of CDMO may either specialize in developing and manufacturing biologics alone, or may offer these same services for biologics and small molecule drugs. Biologics is a general term for drugs manufactured using biotechnology. Unlike small-molecule drugs chemically manufactured, biologics are complex molecules, such as proteins or cells used as medicinal ingredients.
When a pharmaceutical company discovers a new medical biologic, it may choose to partner with a biologics CDMO to outsource one or more steps of the development and manufacturing process. Some biologics CDMOs focus on supporting certain parts of the development process, while full-service biologics CDMOs have the capability to handle each stage of drug development and manufacturing. Biologics CDMOs are valuable resources for pharmaceutical companies, as they have extensive experience navigating everything from pre-formulation to clinical trials and commercial production.
The global biologics CDMO market was valued at nearly $REDACTED billion in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach $REDACTED billion by the end of 2028. Growth in this market is fueled by the increasing R&D activities, prevalence of chronic diseases, rising demand for biologics, increasing aging populations, continuing investment in healthcare infrastructure, and the perpetual parade of new products.
In this report, the global market for biologics CDMO is segmented into product type, cell line type and geographic region. Product types include biologics and biosimilars.
Biologics CDMO companies are concentrating on pharmaceutical and biotechnology companies to provide services for drug development. For instance, in April 2022, ChimeronBio signed a manufacturing agreement with FujiFilm Diosynth Biotechnologies (FDB) to expand its oncology portfolio to include clinics. ChimeronBio selected FDB as its partner for transferring and scaling its drug substance manufacturing process.
The global market for biologics CDMO by cell line type is categorized into mammalian, microbial and other modalities. The mammalian segment is expected to increase from $REDACTED billion in 2022 to $REDACTED billion by the end of 2028, at a CAGR of REDACTED% for the period.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market Overview
Introduction
Benefits of Biologics CDMOs
Expertise
Equipment and Manufacturing Facilities
Scalability
Benefits of Outsourcing
Drawbacks to Outsourcing
Contract Manufacturing
Types of Contract Manufacturers
Evolution of Contract Manufacturing Organizations
Outsourcing
Criteria for Evaluating a Contract Manufacturer
Core Capabilities of CMOs
Core Functional Areas Requiring Constant Attention
Criteria for Selecting an Outsourcing Partner
Top Sources of Dissatisfaction
Challenges in Contract Manufacturing
Services Offered by CMOs
Contract Research
Selecting a CRO
Services Offered by CROs
Checklist for Selecting a CRO
Benefits of Using a CRO
Client/CRO Relationship
Chapter 4 Market Dynamics
Market Drivers
Rising Prevalence of Cancer
Increasing Demand for Biologics
Rising Use of CDMOs
Increasing Elderly Population
Market Restraints
Biologic Product Costs and Price Controls
Capacity Constraints
Manufacturing Costs
Market Opportunities
Co-development of Biosimilars
Chapter 5 Global Market for Biologics CDMOs by Product Type
Introduction
Biologics
Biosimilars
Biologics
Biosimilars
Chapter 6 Global Market for Biologics CDMOs by Cell-Line Type
Mammalian
Microbial (Non-mammalian)
Other Modalities
Chapter 7 Global Market for Biologics CDMOs by Region
Market Overview and Discussion
North America
Europe
Asia-Pacific
RoW
Chapter 8 Sustainability in Biologics CDMOs: An ESG Perspective
Introduction to ESG
Sustainability in Biologics CDMO Industry: An ESG Perspective
Key ESG Issues
Attitudes toward ESG
Industry ESG Performance Analysis
Toyobo and ESG
Concluding Remarks from BCC Research
Chapter 9 Emerging Technologies and Developments
Overview
Big Data, AI and ML
Single-use Technology
Process Analytical Technology (PAT)
Chapter 10 Regulatory Landscape
Regulation of Biologics Services
FDA Regulations
European Regulations
Impact of FDA Regulations
The Declaration of Helsinki
CDISC Standards
Chapter 11 M&A and Venture Funding Outlook
M&A Analysis
Recent News
Chapter 12 Competitive Intelligence
Chapter 13 Company Profiles
ABBVIE PHARMACEUTICAL CONTRACT MANUFACTURING
AGC BIOLOGICS
BOEHRINGER INGELHEIM BIOXCELLENCE
BINEX CO. LTD.
BIOVIAN OY
BORA PHARMACEUTICAL CDMO
CATALENT INC
CYTOVANCE BIOLOGICS
EMERGENT BIOSERVICES
FUJIFILM DIOSYNTH BIOTECHNOLOGIES
ICON PLC
JRS PHARMA GMBH & CO. KG
KEMWELL
LONZA GROUP
LOTTE BIOLOGICS
PAREXEL INTERNATIONAL CORP.
RENTSCHLER BIOPHARMA SE
SAMSUNG BIOLOGICS
SANDOZ INTERNATIONAL GMBH
THERMO FISHER SCIENTIFIC INC.
TOYOBO CO. LTD.
WUXI XDC
Chapter 14 Appendix
List of Tables
Summary Table : Global Market for Biologics CDMOs, by Region, Through 2028
Table 1 : 65-and Over Population, by Region, 2019 And 2050
Table 2 : Global Market for Biologics CDMOs, by Product Type, Through 2028
Table 3 : Global Market for Biologics, by Region, Through 2028
Table 4 : Global Market for Biosimilars, by Region, Through 2028
Table 5 : Global Market for Biologics CDMOs, by Cell-Line Type, Through 2028
Table 6 : Global Market for Mammalian Biologics CDMOs, by Region, Through 2028
Table 7 : Global Market for Microbial Biologics CDMOs, by Region, Through 2028
Table 8 : Global Market for Other Modalities for Biologics CDMOs, by Region, Through 2028
Table 9 : Global Market for Biologics CDMOs, by Region, Through 2028
Table 10 : North American Market for Biologics CDMOs, by Country, Through 2028
Table 11 : European Market for Biologics CDMOs, by Country, Through 2028
Table 12 : Asia-Pacific Market for Biologics CDMOs, by Country, Through 2028
Table 13 : RoW Market for Biologics CDMOs, Through 2028
Table 14 : Key Focus Areas in ESG Metrics
Table 15 : Net-Zero GHG Commitments, by Major Biologics CDMOs
Table 16 : ESG Rankings for Major Biologics CDMO Companies, 2023*
Table 17 : CDP's Scope Card for Major Biologics CDMO Companies, 2022
Table 18 : Ranking of Biologics CDMOs
Table 19 : Boehringer Ingelheim: Revenue, 2020-2022
Table 20 : Boehringer Ingelheim: Revenue, by Business, 2020-2022
Table 21 : Boehringer Ingelheim: Revenue, by Region, 2020-2022
Table 22 : Bora Pharmaceutical: Revenue, 2021 and 2022
Table 23 : Bora Pharmaceutical: Revenue, by Product, 2021 and 2022
Table 24 : Bora Pharmaceutical: Revenue, by Region, 2021 and 2022
Table 25 : Catalent Inc.: Revenue, 2020 and 2022
Table 26 : Catalent Inc.: Revenue, by Business Segment, 2020-2022
Table 27 : Catalent Inc.: Revenue, by Region, 2020-2022
Table 28 : Emergent Bioservices: Development and Manufacturing Services
Table 29 : Emergent Biosolutions: Revenue, by Segment, 2021 and 2022
Table 30 : Emergent Biosolutions: Revenue, by Region, 2021-2022
Table 31 : FujiFilm Diosynth Biotechnologies: Services
Table 32 : ICON plc: Revenue, by Region, 2020-2022
Table 33 : Lonza: Revenue, 2020-2022
Table 34 : Lonza: Revenue, by Operating Segment, 2020-2022
Table 35 : Lonza: Revenue Share, by Region, 2020-2022
Table 36 : Samsung Biologics: Revenue, 2020-2022
Table 37 : Samsung Biologics: Revenue, by Operating Segment, 2020-2022
Table 38 : Sandoz: CDMO Services Across Technology Segments
Table 39 : Sandoz: Revenue, 2020-2022
Table 40 : Sandoz: Revenue, by Business Segment, 2020-2022
Table 41 : Sandoz: Revenue, by Region, 2020-2022
Table 42 : Thermo Fisher Scientific Inc.: Revenue, by Segment
Table 43 : Thermo Fisher Scientific Inc.: Revenue, by Segment
Table 44 : Thermo Fisher Scientific Inc.: Revenue, by Region
Table 45 : Toyobo Co. Ltd.: Revenue, 2020-2022
Table 46 : WuXi Biologics: Products and Services
Table 47 : WuXi Biologics: Revenues by Goods and Services, 2020-2022
Table 48 : WuXi Biologics: Revenue, by Region, 2020-2022
Table 49 : Acronyms
List of Figures
Summary Figure A : Global Market for Biologics CDMOs, by Region, 2020-2028
Summary Figure B : Global Market Shares of Biologics CDMOs, by Region, 2022
Figure 1 : Role of Contract Service Providers in the Pharmaceutical Value Chain
Figure 2 : CDMO Services
Figure 3 : Global Market for Biologics CDMOs, by Product Type, 2020-2028
Figure 4 : Global Market Shares of Biologics CDMOs, by Product Type, 2022
Figure 5 : Global Market for Biologics, by Region, 2020-2028
Figure 6 : Global Market Shares of Biologics, by Region, 2022
Figure 7 : Global Market for Biosimilars, by Region, 2020-2028
Figure 8 : Global Market Shares of Biosimilars, by Region, 2022
Figure 9 : Global Market for Biologics CDMOs, by Cell-Line Type, 2020-2028
Figure 10 : Global Market Shares of Biologics CDMOs, by Cell-Line Type, 2022
Figure 11 : Global Market for Mammalian Biologics CDMOs, by Region, 2020-2028
Figure 12 : Global Market Shares of Mammalian Biologics CDMOs, by Region, 2022
Figure 13 : Global Market for Microbial Biologics CDMOs, by Region, 2020-2028
Figure 14 : Global Market Shares of Microbial Biologics CDMOs, by Region, 2022
Figure 15 : Global Market for Other Modalities for Biologics CDMOs, by Region, 2020-2028
Figure 16 : Global Market Shares of Other Modalities for Biologics CDMO, by Region, 2022
Figure 17 : Global Market for Biologics CDMOs, by Region, 2020-2028
Figure 18 : Global Market Shares of Biologics CDMOs, by Region, 2022
Figure 19 : North American Market for Biologics CDMOs, by Country, 2020-2028
Figure 20 : North American Market Shares of Biologics CDMOs, by Country, 2022
Figure 21 : European Market for Biologics CDMOs, by Country, 2020-2028
Figure 22 : European Market Shares of Biologics CDMOs, by Country, 2022
Figure 23 : Asia-Pacific Market for Biologics CDMOs, by Country, 2020-2028
Figure 24 : Asia-Pacific Market Shares of Biologics CDMOs, by Country, 2022
Figure 25 : How A Strong ESG Proposition Can Benefit Businesses
Figure 26 : Level of ESG Adoption across All Industries
Figure 27 : Business Sustainability Trends
Figure 28 : Toyobo Co. Ltd. ESG Focus Areas
Figure 29 : Emerging Technologies in the Biologics CDMO Market
Figure 30 : FDA cGMP Manufacturing Guidance Documents
Figure 31 : FDA Site Inspections
Figure 32 : European cGMP Guideline Documentation
Figure 33 : European Site Inspection Outcomes
Figure 34 : Boehringer Ingelheim: Revenue Share, by Business, 2022
Figure 35 : Boehringer Ingelheim: Revenue Share, by Region, 2022
Figure 36 : Bora Pharmaceutical: Revenue Share, by Product, 2022
Figure 37 : Bora Pharmaceutical: Revenue Share, by Region, 2022
Figure 38 : Catalent Inc.: Revenue Share, by Business Segment, 2022
Figure 39 : Catalent Inc.: Revenue Share, by Region, 2022
Figure 40 : Emergent Biosolutions: Revenue Share, by Segment, 2022
Figure 41 : Emergent Biosolutions: Revenue Share, by Region, 2022
Figure 42 : ICON plc: Company Revenue, 2020-2022
Figure 43 : Icon plc: Revenue Share, by Region, 2022
Figure 44 : Lonza: Revenue Share, by Operating Segment, 2022
Figure 45 : Lonza: Revenue Share, by Region, 2022
Figure 46 : Samsung Biologics: Revenue Share, by Operating Segment, 2022
Figure 47 : Sandoz: Revenue Share, by Business Segment, 2022
Figure 48 : Sandoz: Revenue Share, by Region, 2022
Figure 49 : Thermo Fisher Scientific Inc.: Revenue, 2020-2022
Figure 50 : Thermo Fisher Scientific Inc.: Revenue Share, by Segment, 2022
Figure 51 : Thermo Fisher Scientific Inc.: Revenue Share, by Segment, 2022
Figure 52 : Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022
Figure 53 : Toyobo Co. Ltd.: Revenue Share, by Operating Segment, 2022
Figure 54 : WuXi Biologics: Company Revenue, 2020-2022
Figure 55 : WuXi Biologics: Revenues by Goods and Services, 2020-2022
Figure 56 : WuXi Biologics: Revenue Share, by Region, 2020-2022
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security